today we will talk about Nifuroxazide uses and side effects from all points of view
Nifuroxazide (INN) is an oral nitrofuran antibiotic, patented since 1966
and used to treat colitis and diarrhea in humans and non-humans.
It is sold under the brand names Ambatrol, Antinal, Bacifurane, Diafuryl, Pérabacticel (France), Antinal, Diax (Egypt), Nifrozid, Ercefuryl (Romania, Czech Republic, Russia),
Erfuzide (Thailand), Endiex (Slovakia), Enterofuryl (Russia), Nifuroksazyd (Poland), Pentofuryl (Germany), Topron, Enterovid (Latin America), Eskapar (Mexico), Enterocolin (Bolivia), Apazid (Morocco) and Septidiaryl. It is sold in capsule form and also as a suspension. The pharmaceutical group GlaxoSmithKline plc (Previously known as SmithKline Beecham) claims that nifuroxazide is highly effective and the consumers' group Healthy Skepticism says that GlaxoSmithKline's claims have no scientific support.
In 1997, in an Ivory Coast promotional leaflet, GlaxoSmithKline
claimed that nifuroxazide (under the brand name "Ambatrol") is
an anti-dehydration treatment, "neutralise[s] microbacterials" in
diarrhea, and has "a spectrum which covers most enteropathogenic
microbacterials, Shigella, Escherichia coli, Salmonella, Staphylococci, Klebsiella, Yersinia".[
The international non-profit organisation Healthy Skepticism, at the time using their former name, Medical Lobby for Appropriate Marketing (MaLAM), disagreed, stating "We have not found any scientific evidence to support these claims.
